Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying ...
Collaboration will evaluate Scenic's first-in-class PLA2G15 inhibitor program in Parkinson's diseaseLeveraging MJFF’s LITE consortium and world-class LRRK2 biology and biomarker infrastructure to test ...
That’s from a new survey by Resume Genius in its 2026 Salary Negotiation and Expectations Survey, for which the company ...
Gen Z candidates are the most likely to negotiate pay, the survey found. More than half of that generation surveyed (55%) ...
Vontier Corporation (NYSE: VNT), a leading global provider of critical technologies and solutions to connect, manage and ...
This year is the halfway point in the implementation of the 2030 Agenda for Sustainable Development. A global pandemic, conflicts, disasters and other crises have set back progress towards the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results